This study is designed to test the safety and effectiveness of a new drug Dideoxyiosine (DDI) in preventing infection and prolonging survival in HIV infected patients who are intolerant of zidovudine because of toxic effects on their blood cells.
Showing the most recent 10 out of 869 publications